• Home
  • HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.

HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.

Author List
Alyamani M, Emamekhoo H, Park S, Taylor J, Almassi N, Upadhyay S, Tyler A, Berk MP, Hu B, Hwang TH, Figg WD, Peer CJ, Chien C, Koshkin VS, Mendiratta P, Grivas P, Rini B, Garcia J, Auchus RJ, Sharifi N
Publication
The Journal of clinical investigation
Publication ID (Profile URL)
https://researcherprofiles.org/profile/23315740
Publication Year
2018
PubMed ID
29939161
Publication Title
Alyamani M, Emamekhoo H, Park S, Taylor J, Almassi N, Upadhyay S, Tyler A, Berk MP, Hu B, Hwang TH, Figg WD, Peer CJ, Chien C, Koshkin VS, Mendiratta P, Grivas P, Rini B, Garcia J, Auchus RJ, Sharifi N. HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. J Clin Invest. 2018 08 01; 128(8):3333-3340.